Home  |  About  |  Contact  |  Join MCACS  Donate to MCACS
Massachusetts Chapter of the American College of Surgeons Massachusetts Chapter of the American College of Surgeons Massachusetts Chapter of the American College of Surgeons Massachusetts Chapter of the American College of Surgeons Massachusetts Chapter of the American College of Surgeons
57th Annual Meeting Abstracts


Poster 22

Abstract Title

Preoperative Infliximab And Short-Term Complications After Ileal Pouch-Anal Anastomosis

 

Author Block

Melanie L. Gainsbury MD, Daniel I. Chu MD, Lauren A. Howard MPH, Jennifer A. Coukos BS, Francis A. Farraye MD MSc, Arthur F. Stucchi PhD, James M. Becker MD FACS

Department of Surgery and Section of Gastroenterology, Boston UniversitySchool of Medicine,Boston, MA

 

Abstract Body

Introduction: Considerable controversy exists over whether the preoperative use of infliximab (IFX) for refractory ulcerative colitis (UC) increases the risk for surgical complications after restorative proctocolectomy and ileal pouch-anal anastomosis (IPAA). The aim of this study was to assess the association between preoperative IFX use and short-term surgical complications in a single-surgeon cohort at a tertiary care academic center.

Methods: UC patients who underwent IPAA from September 2005 through May 2009 were retrospectively identified. Twenty-nine patients treated with IFX within 12-weeks of surgery and 52 non-IFX control subjects were identified. Short-term postoperative outcomes, defined as having occurred between the first-stage IPAA surgery until up to within 30 days after loop ileostomy closure, were compared between groups.

Results: Patients were similar with respect to demographics, co-morbidities, rate of emergency surgery, hand-sewn anastomosis and preoperative use of cyclosporine, azathioprine and high-dose steroids. IFX patients were more likely to have received a laparoscopic hand-assisted IPAA, low-, medium- and any-dose steroids, 6-mercaptopurine (6-MP), methotrexate, and to have failed medical therapy. There was no short-term mortality. Overall postoperative and infectious complications were similar between IFX and non-IFX groups. Multivariate regression models revealed no independent predictors for postoperative complications when including IFX (odds ratio (OR) 0.78, p=0.67), laparoscopic hand-assisted IPAA, 6-MP, methotrexate, steroids, failure of medical therapy and body mass index (BMI).

Conclusions: Preoperative IFX use was not associated with an increased risk of short-term postoperative complications after IPAA.

 

 Home | About | Contact